Tag: JNK
-
How Zilganersen Targets Alexander Disease by Reducing GFAP RNA
Zilganersen is a GFAP-targeting antisense oligonucleotide that reduces GFAP production upstream of protein accumulation, astrocyte stress and white-matter injury in Alexander disease.